NICE endorses dacomitinib for treatment of lung cancer
Vizimpro (dacomitinib) has been recommended as a first-line treatment option…
Vizimpro (dacomitinib) has been recommended as a first-line treatment option for patients with lung cancer.
List view / Grid view
Vizimpro (dacomitinib) has been recommended as a first-line treatment option…
Vizimpro (dacomitinib) has been recommended as a first-line treatment option for patients with lung cancer.
A CAR-T immunotherapy for adults with an aggressive form of…
A CAR-T immunotherapy for adults with an aggressive form of non-Hodgkin lymphoma has been provisionally rejected by the NHS...